药理性血栓预防治疗VTE静脉瘤静脉静脉切除后:网络元分析
Daniel Westby1, Sara Gasior1, Mark Twyford1
1Department of Vascular and Endovascular Surgery, University Hospital Galway, Galway, Ireland.
Vascular and endovascular surgery
|April 12, 2024
概括
里瓦罗克萨班是预防静脉除后血栓的最佳抗凝剂,与其他选择相比,它提供了优越的血栓预防,降低了出血风险. 对抗凝血药的临床决定仍由医生做.
科学领域:
- 血管外科 血管外科
- 药理学 药理学是指药理学的学科.
- 基于证据的医学基于证据的医学.
背景情况:
- 静脉内移除是一种常见的静脉静脉治疗方法,但具有静脉血栓栓塞的风险.
- 目前针对抽血后患者的抗凝血方案缺乏共识.
- 优化抗凝剂治疗对于患者的安全至关重要.
研究的目的:
- 进行一个网络元分析 (NMA),比较用于内静脉切除后的抗凝剂.
- 为了确定最佳的抗凝剂,以预防凝血.
- 评估与不同抗凝剂相关的不良出血事件的风险.
主要方法:
- 在图书馆数据库中搜索了有关血管内膜切除后抗凝剂的相关研究.
- 使用偏差风险 (ROB) 工具量化研究质量.
- 通过使用统计软件,分析了近1500名患者的观察数据.
主要成果:
- 里瓦罗克萨班,埃诺克萨巴林和芬达帕鲁努克斯在接受缩静脉切除的患者中进行了分析.
- 里瓦罗克萨班在预防血栓事件方面表现出优越性.
- 还考虑了出血事件的发生率,里瓦洛克萨班显示低风险.
结论:
- 预防性里瓦罗克萨班是治疗静脉瘤内静脉切除后的血栓预防的主要抗凝剂.
- 里瓦洛克萨班在血液出血风险方面提供了良好的疗效与安全平衡.
- 使用抗凝血剂的决定仍由临床医生自行决定.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
689
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
689
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Esophageal Varices-II: Clinical Features and Management
60
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
60
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Vascular Spasm
1.4K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.4K
Clot Retraction and Fibrinolysis
5.7K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.7K


